Literature DB >> 3633237

Complement activation in human lymph: modulation by the contact activation system and by leukocytes.

W Vogt, B Damerau, B Lühmann, D Hesse, Y Haller.   

Abstract

Complement components, their activation and the generation of C3a and C5a peptides were studied in human lymph used as a model of tissue fluid. Both, classical and alternative pathways could be activated by suitable agents such as immune aggregates or zymosan. C3 activation and C3a formation were marked while only 10-15% of the anyway low amount of C5 were converted during complement activation, yielding very low concentrations of C5a. Carboxypeptidase N activity was present in lymph and converted the peptides to their less (C5a) or not at all (C3a) active desArg derivatives. Contact activation of Hageman factor and kallikrein enhanced activation of the classical pathway up to C3 conversion. The search for additional processes apt to create efficient concentrations of C5a (desArg) in lymph led to the discovery that the presence of leukocytes in lymph greatly increases the release of C5a activity upon complement activation. This suggests a physiological role of leukocytes resident in tissues for the induction of inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3633237     DOI: 10.1159/000234013

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  5 in total

Review 1.  The role of complement in inflammatory diseases from behind the scenes into the spotlight.

Authors:  Maciej M Markiewski; John D Lambris
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

Review 2.  Complement inhibition as a proposed neuroprotective strategy following cardiac arrest.

Authors:  Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Peter A DeRosa; Andrew F Ducruet; E Sander Connolly
Journal:  Mediators Inflamm       Date:  2010-01-26       Impact factor: 4.711

3.  Complement profiles in human skin lymph during the course of irritant contact dermatitis.

Authors:  C U Brand; P J Späth; T Hunziker; A Limat; L R Braathen
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

Review 4.  The role of the complement system in metabolic organs and metabolic diseases.

Authors:  Julia Phieler; Ruben Garcia-Martin; John D Lambris; Triantafyllos Chavakis
Journal:  Semin Immunol       Date:  2013-05-17       Impact factor: 11.130

5.  Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection.

Authors:  Michael Huber; Marek Fischer; Benjamin Misselwitz; Amapola Manrique; Herbert Kuster; Barbara Niederöst; Rainer Weber; Viktor von Wyl; Huldrych F Günthard; Alexandra Trkola
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.